Mannitol
(Osmitrol, Resectisol)
|
Category:
Description:
Indications:
-
Reduction
of intracranial pressure associated with cerebral edema
-
Reduction
of intraocular pressure
-
Improve
renal function in oliguric phase of acute renal failure
-
Promote
urinary excretion of toxic substances
Contraindications:
Precautions:
Adverse
Reactions (Side Effects):
-
CNS:
confusion, dizziness, seizures, headache, rebound increased
intracranial pressure
-
CV:
angina-like chest pain, CHF, edema, hypertension, hypotension,
tachycardia, thrombophlebitis
-
EENT:
blurred vision, loss of hearing, nasal congestion
-
GU:
osmotic necrosis, urinary retention
-
METAB:
acidosis, dehydration, electrolyte loss, fluid and electrolyte
imbalances
-
SKIN:
skin necrosis, urticaria
-
MISC:
chills, fever
|
Dosage:
Administered
intravenously
|
Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington,
D.C., 20372-5300
|